- Filed
- Mar 27, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | FY 2024 · Dec 31, 2023 | 18.23M sh |
| Capex | FY 2024 · Dec 31, 2023 | $5M |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | $5.24M |
| Long Term Debt | FY 2024 · Dec 31, 2023 | $14.62M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $27.44M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $41.87M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $56.5M |
| Current Assets | FY 2024 · Dec 31, 2023 | $56.46M |
| Total Assets | FY 2024 · Dec 31, 2023 | $76.85M |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −$0.21 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −$0.21 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $43.91M |
| Rd Expense | FY 2024 · Dec 31, 2023 | $7.54M |
| Net Income | FY 2024 · Dec 31, 2023 | −$3.85M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$2.07M |
| Cost Of Revenue restated | FY 2024 · Dec 31, 2023 | $22.89M |
| Revenue | FY 2024 · Dec 31, 2023 | $59.66M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $16.98M |